437 related articles for article (PubMed ID: 9932882)
1. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain.
Anderson VC; Burchiel KJ
Neurosurgery; 1999 Feb; 44(2):289-300; discussion 300-1. PubMed ID: 9932882
[TBL] [Abstract][Full Text] [Related]
2. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy.
Kumar K; Kelly M; Pirlot T
Surg Neurol; 2001 Feb; 55(2):79-86; discussion 86-8. PubMed ID: 11301086
[TBL] [Abstract][Full Text] [Related]
3. Continuous infusion of opioid and bupivacaine by externalized intrathecal catheters in long-term treatment of "refractory" nonmalignant pain.
Nitescu P; Dahm P; Appelgren L; Curelaru I
Clin J Pain; 1998 Mar; 14(1):17-28. PubMed ID: 9535310
[TBL] [Abstract][Full Text] [Related]
4. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain.
Rauck RL; Cherry D; Boyer MF; Kosek P; Dunn J; Alo K
J Pain; 2003 Oct; 4(8):441-7. PubMed ID: 14622664
[TBL] [Abstract][Full Text] [Related]
5. Improvement in psychosocial outcomes in chronic pain patients receiving intrathecal morphine infusions.
Duse G; Davià G; White PF
Anesth Analg; 2009 Dec; 109(6):1981-6. PubMed ID: 19923529
[TBL] [Abstract][Full Text] [Related]
6. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R
Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491
[TBL] [Abstract][Full Text] [Related]
7. Long-term intrathecal drug administration for chronic nonmalignant pain.
Duarte RV; Raphael JH; Sparkes E; Southall JL; LeMarchand K; Ashford RL
J Neurosurg Anesthesiol; 2012 Jan; 24(1):63-70. PubMed ID: 21904220
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of intrathecal drug delivery system for intractable pain in advanced malignancies: A prospective cohort study.
Zheng S; He L; Yang X; Li X; Yang Z
Medicine (Baltimore); 2017 Mar; 96(11):e6354. PubMed ID: 28296770
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice.
Alicino I; Giglio M; Manca F; Bruno F; Puntillo F
Pain; 2012 Jan; 153(1):245-249. PubMed ID: 22082570
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal morphine delivered via subcutaneous pump for intractable pain in pancreatic cancer.
Gilmer-Hill HS; Boggan JE; Smith KA; Frey CF; Wagner FC; Hein LJ
Surg Neurol; 1999 Jan; 51(1):6-11. PubMed ID: 9952116
[TBL] [Abstract][Full Text] [Related]
12. Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient Satisfaction.
Brogan SE; Winter NB; Okifuji A
Reg Anesth Pain Med; 2015; 40(4):369-75. PubMed ID: 25923819
[TBL] [Abstract][Full Text] [Related]
13. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain.
Webster LR; Fakata KL; Charapata S; Fisher R; MineHart M
Pain Med; 2008 Apr; 9(3):282-90. PubMed ID: 18366508
[TBL] [Abstract][Full Text] [Related]
14. Chronic intrathecal morphine for intractable pain.
Penn RD; Paice JA
J Neurosurg; 1987 Aug; 67(2):182-6. PubMed ID: 3598678
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and technical complications of long-term continuous intraspinal infusions of opioid and/or bupivacaine in refractory nonmalignant pain: a comparison between the epidural and the intrathecal approach with externalized or implanted catheters and infusion pumps.
Dahm P; Nitescu P; Appelgren L; Curelaru I
Clin J Pain; 1998 Mar; 14(1):4-16. PubMed ID: 9535309
[TBL] [Abstract][Full Text] [Related]
16. Spinal cord compression by catheter granulomas in high-dose intrathecal morphine therapy: case report.
Cabbell KL; Taren JA; Sagher O
Neurosurgery; 1998 May; 42(5):1176-80; discussion 1180-1. PubMed ID: 9588567
[TBL] [Abstract][Full Text] [Related]
17. A Prospective, Randomized, Single-Blinded, Head-to-Head Long-Term Outcome Study, Comparing Intrathecal (IT) Boluses With Continuous Infusion Trialing Techniques Prior to Implantation of Drug Delivery Systems (DDS) for the Treatment of Severe Intractable Chronic Nonmalignant Pain.
Hamza M; Doleys DM; Saleh IA; Medvedovsky A; Verdolin MH; Hamza M
Neuromodulation; 2015 Oct; 18(7):636-48; discussion 649. PubMed ID: 26307558
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology.
Winkelmüller M; Winkelmüller W
J Neurosurg; 1996 Sep; 85(3):458-67. PubMed ID: 8751633
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience.
Lin CP; Lin WY; Lin FS; Lee YS; Jeng CS; Sun WZ
J Formos Med Assoc; 2012 May; 111(5):253-7. PubMed ID: 22656395
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous treatment of intractable pain and spasticity: observations of combined intrathecal baclofen-morphine therapy over a 10-year clinical experience.
Saulino M
Eur J Phys Rehabil Med; 2012 Mar; 48(1):39-45. PubMed ID: 21525824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
